Emanuela B.
- Country
- Italy
- Department
- Interventional Pulmonoligist
Research Overview
- Efficacy and Safety Evaluation of Buloxibutid in Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Evaluation of BI 1819479 Efficacy, Safety, and Dose-Response in Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of BI 1839100 in Reducing Cough Frequency in Idiopathic and Progressive Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 76 of 224 partner sites.
Specializations
Pulmonary Fibrosis Research
The investigator specializes in treating patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), focusing on innovative therapeutic approaches to improve patient outcomes.
- Lung Function Enhancement
- Cough Management
- Disease Progression Control
Their work encompasses therapeutic interventions aimed at addressing key symptoms and improving respiratory function in fibrotic lung conditions.
Respiratory Symptom Management
The investigator has particular expertise in addressing chronic cough associated with pulmonary fibrosis, exploring treatments that target this challenging symptom.
- 24-hour Cough Frequency Assessment
- Therapeutic Response Evaluation
- Long-term Symptom Control
Their research focuses on quantifiable improvements in cough reduction and patient comfort.
Treatment Optimization
The investigator conducts research in dose-response relationships for novel therapeutic agents, seeking to establish optimal treatment parameters for pulmonary conditions.
- Dose-Response Analysis
- Treatment Effect Quantification
- Safety Profile Assessment
Their approach encompasses careful evaluation of therapeutic efficacy across different dosing regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.